Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, MO
Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD). We are evaluating a study medication compared to placebo on arterial stiffness.
The study can last up to 26 weeks and can require up to 6 office visits and one follow-up telephone call. At each visit, the safety and effectiveness of the study medication will be monitored and study procedures performed. We are evaluating the effectiveness of investigational study drug to placebo on arterial stiffness measurements. Additionally, compensation for time and travel may be provided.
Patient Inclusion Criteria:
- Are at least 40 years of age.
- Have been diagnosed with COPD
- Are a current or former smoker
Patient Exclusion Criteria:
- Current diagnosis of asthma
- Morbid Obesity
- Alcohol or drug abuse within the last two years
- History (within the last 5 years) or current diagnosis of cancer
- Cannot have been taking an antibiotic in the last 4 weeks
Mitchell Champagne RPh, CCRC, Research Director
Midwest Chest Consultants, PC
330 First Capitol Drive
St. Charles, MO 63301
Research Center Information: Midwest Chest Consultants, PC
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these